+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Bioconjugation Market by Product (Consumables, Instruments (Chromatography, Spectrometry)), Service (Conjugation, Analytical), Technique (Chemical, Click Chemistry), Biomolecule (Antibodies), Application (Therapeutics (ADC), R&D) - Global Forecast to 2029

  • PDF Icon

    Report

  • 677 Pages
  • October 2024
  • Region: Global
  • Markets and Markets
  • ID: 6019659
The bioconjugation market is expected to grow to USD 10.86 billion by 2029, up from USD 5.27 billion in 2024, at a CAGR of 15.6% between 2024 and 2029. Several key factors impact the growth of the bioconjugation market. The development of targeted therapeutics such as ADCs is expected to be greatly supported by bioconjugation, as the need for more accurate and potent cancer treatments grows. Furthermore, there is a growing focus on technological developments and outsourcing services. Furthermore, emerging countries provide significant development opportunities, and the expanding applications of bioconjugation are expected to drive the market further.

The antibody conjugation segment accounted for the largest share of by conjugation type segment for the bioconjugation services market in 2023.

In 2023, the antibody conjugation segment accounted for the largest share of the global bioconjugation services market by conjugation type. The antibody conjugation segment dominates the bioconjugation services market because it is widely used in developing targeted treatments, particularly for cancer. Antibody-drug conjugates (ADCs) enable accurate drug delivery by targeting specific antigens on tumor cells, minimizing off-target effects and toxicity. The favourable results of ADCs in clinical trials, as well as their approval to treat a variety of malignancies, including HER2-positive breast cancer, have increased demand for antibody-based conjugation services.

The antibodies segment accounted for the largest share of by biomolecule type segment for the bioconjugation products market in 2023.

In 2023, the antibodies segment accounted for the largest share of the global bioconjugation products market by biomolecule type. The most prominent biomolecule type in the bioconjugation products market is antibodies, especially monoclonal antibodies, which are dominantly used in the development of Antibody-Drug Conjugates (ADCs) with higher accuracy in targeting. Antibodies are integrally used in oncology and have led to several FDA-approved ADC therapies such as Adcetris and Kadcyla. These therapeutic antibodies conjugated with cytotoxic drugs through bioconjugation techniques allow for targeted treatment while minimizing systemic toxicity. Increasing clinical trials and FDA approvals for the drugs based on antibodies further drive the growth of this segment.

In 2023, the US remained to dominate the bioconjugation market.

The US dominated the North American bioconjugation market in 2023. The US is the world's largest biopharmaceutical market and the leader in biopharmaceutical research and investment. The United States also has a strong healthcare infrastructure, which encourages research and development in the life sciences. Additionally, the significant presence of many biopharmaceutical companies and growing research activities in the biotechnology industry are propelling market growth in the US. Moreover, the growing prevalence of cancer is also driving the growth of the bioconjugation market.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the bioconjugation marketplace.
  • By Respondent: Supply Side - 70% and Demand Side 30%
  • By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
  • By Region: North America - 40%, Europe - 25%, Asia-Pacific - 25%, Latin America - 5% and Middle East & Africa - 5%
Danaher Corporation (US); Lonza (Switzerland); Thermo Fisher Scientific Inc. (US); Merck KGaA (Germany); AbbVie Inc. (US); WuXi Biologics (Cayman) Inc. (China); Sartorius AG (Germany); are some of the key players in the bioconjugation market.

The study includes an in-depth competitive analysis of these key players in the bioconjugation market, with their company profiles, recent developments, and key market strategies.

Research Coverage:

This research report categorizes the bioconjugation market by product type (consumables { reagents and kits [linker and crosslinking reagents & kits, labeling reagents & kits, modification reagents & kits, other reagents & kits], labels [fluorescent tags, enzymes, haptens, polymers, bead coupling, other labels], other consumables}, instruments {chromatography systems, mass spectrometers, spectroscopy instruments, flow cytometers, electrophoresis equipment, filtration systems, mixers/shakers, incubators, other instruments}]), technique (chemical conjugation, click chemistry, enzyme-mediated conjugation, photoreactive crosslinking, other techniques), biomolecule type (antibodies, peptides, proteins, oligonucleotides, other biomolecules), application (therapeutics {antibody-drug conjugates (ADCs), peptide-drug conjugates, protein-drug conjugates, other therapeutic applications}, research & development, diagnostics), end user (pharmaceutical & biotechnology companies, CROs & CMOs, academic & research institutes, hospitals and clinical/diagnostic laboratories), service type (custom synthesis & conjugation services, analytical & characterization services, scale-up & manufacturing services, other services), technique (chemical conjugation, click chemistry, enzyme-mediated conjugation, photoreactive crosslinking, other techniques), conjugation type (antibody conjugation, peptide conjugation, protein conjugation, oligonucleotide conjugation, other conjugation services), application (therapeutics, research & development, diagnostics), end user (pharmaceutical & biotechnology companies, academic & research institutes, hospitals and clinical/diagnostic laboratories), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the bioconjugation market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations and acquisitions, and recent developments associated with the bioconjugation market.

Reasons to buy this report

The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall bioconjugation market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (growing demand for targeted therapies, increasing investments in biopharmaceutical R&D, rising demand for outsourcing services, expanding pipeline of bioconjugated drugs, advancements in bioconjugation technologies), restraints (high cost of bioconjugate development & manufacturing, stringent regulatory requirements), opportunities (high growth potential of emerging economies, expanding applications of bioconjugation), and Challenges (technical complexities) influencing the growth of the market.
  • Product/Service Development/Innovation: Detailed insights on newly launched products/services of the bioconjugation market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the bioconjugation market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and product/service offerings of leading players like Danaher Corporation (US), Lonza (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), AbbVie Inc. (US), WuXi Biologics (Cayman) Inc. (China), Sartorius AG (Germany), Bio-Rad Laboratories, Inc. (US), among others in the market.

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Market Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Estimation Methodology
2.2.1 Market Estimation
2.2.2 Insights from Primary Experts
2.2.3 Top-Down Approach
2.3 Market Growth Rate Projection
2.4 Data Triangulation
2.5 Research Assumptions
2.6 Research Limitations
2.7 Risk Analysis
3 Executive Summary
4 Premium Insights
4.1 Bioconjugation Market Overview
4.2 North America: Bioconjugation Products Market, by Application and Country (2023)
4.3 Bioconjugation Products Market, by Type (2023)
4.4 Bioconjugation Products Market, by End-user (2023)
4.5 Bioconjugation Services Market, by Type (2023)
4.6 Bioconjugation Market: Geographic Growth Opportunities
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Demand for Targeted Therapies
5.2.1.2 Increasing Investments in Biopharmaceutical R&D
5.2.1.3 Rising Demand for Outsourcing Services
5.2.1.4 Expanding Pipeline of Bioconjugate Drugs
5.2.1.5 Advancements in Bioconjugation Technologies
5.2.2 Restraints
5.2.2.1 High Cost of Bioconjugate Development & Manufacturing
5.2.2.2 Stringent Regulatory Requirements
5.2.3 Opportunities
5.2.3.1 High Growth Potential of Emerging Economies
5.2.3.2 Expanding Applications of Bioconjugation
5.2.4 Challenges
5.2.4.1 Technical Complexities
5.3 Trends/Disruptions Impacting Customers’ Businesses
5.4 Pricing Analysis
5.4.1 Indicative Product Pricing Analysis, by Key Player
5.4.2 Indicative Product Pricing Analysis, by Region
5.5 Supply Chain Analysis
5.6 Value Chain Analysis
5.7 Ecosystem Analysis
5.7.1 Bioconjugation Market: Raw Material Suppliers
5.7.2 Bioconjugation Market: Product Manufacturers
5.7.3 Bioconjugation Market: Service Providers
5.7.4 Bioconjugation Market: End-users
5.7.5 Bioconjugation Market: Regulatory Bodies
5.8 Technology Analysis
5.8.1 Key Technologies
5.8.1.1 Chemical Conjugation
5.8.1.2 Enzymatic Conjugation
5.8.1.3 Photochemical Conjugation
5.8.1.4 Click Chemistry
5.8.2 Complementary Technologies
5.8.3 Adjacent Technologies
5.9 Patent Analysis
5.10 Key Conferences & Events
5.11 Regulatory Landscape
5.11.1 Regulatory Scenario
5.11.1.1 North America
5.11.1.1.1 US
5.11.1.1.2 Canada
5.11.1.2 Europe
5.11.1.2.1 Germany
5.11.1.2.2 UK
5.11.1.3 Asia-Pacific
5.11.1.3.1 Japan
5.11.1.3.2 China
5.11.1.4 Latin America
5.11.1.4.1 Brazil
5.11.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.12 Investment & Funding Scenario
5.13 Porter's Five Forces Analysis
5.13.1 Threat of New Entrants
5.13.2 Threat of Substitutes
5.13.3 Bargaining Power of Buyers
5.13.4 Bargaining Power of Suppliers
5.13.5 Intensity of Competitive Rivalry
5.14 Key Stakeholders and Buying Criteria
5.14.1 Key Stakeholders in Buying Process
5.14.2 Buying Criteria for End-users
5.15 Trade Analysis
5.16 Impact of AI/Generative AI on Bioconjugation Market
6 Bioconjugation Products Market, by Type
6.1 Introduction
6.2 Consumables
6.2.1 Reagents & Kits
6.2.1.1 Linker and Crosslinking Reagents & Kits
6.2.1.1.1 Precision in Conjugation Reactions to Boost Demand
6.2.1.2 Labeling Reagents & Kits
6.2.1.2.1 Growing Demand for Enhanced Diagnostic Sensitivity to Fuel Uptake
6.2.1.3 Modification Reagents & Kits
6.2.1.3.1 Uptake of Protein Engineering for Optimal Behavior to Support Market Growth
6.2.1.4 Other Reagents & Kits
6.2.2 Labels
6.2.2.1 Fluorescent Tags
6.2.2.1.1 Rising Demand in Imaging & Diagnostics to Drive Market
6.2.2.2 Enzymes
6.2.2.2.1 Increasing Utilization of Western Blotting & Elisa Kits to Fuel Market
6.2.2.3 Haptens
6.2.2.3.1 Wide Applications in Immunoassays and Vaccine Development to Support Market Growth
6.2.2.4 Polymers
6.2.2.4.1 Advancements in Polymer-based Drug Delivery Systems to Drive Market
6.2.2.5 Bead Coupling
6.2.2.5.1 Utilization in Magnetic Bead-based Immunoassays and Cell Separation to Support Market Growth
6.2.2.6 Other Labels
6.2.3 Other Consumables
6.3 Instruments
6.3.1 Chromatography Systems
6.3.1.1 Ability to Offer Precision and Purification to Drive Market
6.3.2 Mass Spectrometers
6.3.2.1 High Uptake in Bioconjugate Characterization to Drive Market
6.3.3 Spectroscopy Instruments
6.3.3.1 Monitoring of Bioconjugation Reactions in Real-Time to Fuel Uptake
6.3.4 Flow Cytometers
6.3.4.1 Determination of Therapeutic Potential in Adcs to Propel Market
6.3.5 Electrophoresis Equipment
6.3.5.1 Increasing Requirement for Reliable Analysis to Support Market Growth
6.3.6 Filtration Systems
6.3.6.1 High Purity Requirements to Support Market Growth
6.3.7 Mixers & Shakers
6.3.7.1 Ability to Ensure Uniform Conjugation Reactions to Boost Demand
6.3.8 Incubators
6.3.8.1 Integration of Smart Technologies for Controlled Environments to Drive Market
6.3.9 Other Instruments
7 Bioconjugation Products Market, by Technique
7.1 Introduction
7.2 Chemical Conjugation
7.2.1 High Demand for Oncology Adcs and Versatile Technique to Propel Market
7.3 Click Chemistry
7.3.1 Growing Need for Regulatory Compliance and Quality Assurance to Propel Market
7.4 Enzyme-Mediated Conjugation
7.4.1 Increasing Number of Clinical Trials to Boost Demand
7.5 Photoreactive Crosslinking
7.5.1 Development of Light-Activated Therapeutics and Imaging Agents to Support Market Growth
7.6 Other Techniques
8 Bioconjugation Products Market, by Biomolecule Type
8.1 Introduction
8.2 Antibodies
8.2.1 Expanding Therapeutic Applications to Support Market Growth
8.3 Peptides
8.3.1 High Flexibility and Drug Delivery Efficiency to Fuel Uptake
8.4 Proteins
8.4.1 Increasing Development of Elisa and Pdcs in Therapeutic Applications to Drive Market
8.5 Oligonucleotides
8.5.1 Growing Uptake in Gene Therapy to Support Market
8.6 Other Biomolecules
9 Bioconjugation Products Market, by Application
9.1 Introduction
9.2 Therapeutics
9.2.1 Antibody-Drug Conjugates
9.2.1.1 Increasing Demand for Targeted Cancer Therapies to Propel Market
9.2.2 Peptide-Drug Conjugates
9.2.2.1 Advancements in Peptide Synthesis to Boost Demand
9.2.3 Protein-Drug Conjugates
9.2.3.1 Improvements in Bioavailability and Pharmacokinetics of Therapeutic Agents to Drive Market
9.2.4 Other Therapeutic Applications
9.3 Research & Development
9.3.1 Growing Interest in Innovative Therapeutic Modalities to Drive Market
9.4 Diagnostics
9.4.1 Utilization in Diagnostic Assay Development to Support Market Growth
10 Bioconjugation Products Market, by End-user
10.1 Introduction
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Increasing Adoption of Bioconjugation in Targeted Therapies to Drive Market
10.3 Contract Research Organizations (Cros) & Contract Manufacturing Organizations (Cmos)
10.3.1 Increasing Outsourcing of Bioconjugation Services to Propel Market
10.4 Academic & Research Institutes
10.4.1 Increasing Focus on Novel Bioconjugation Techniques for Basic & Applied Research to Fuel Uptake
10.5 Hospitals and Clinical/Diagnostic Laboratories
10.5.1 Expanding Applications of Bioconjugates in Diagnostics & Therapeutics to Support Market Growth
11 Bioconjugation Services Market, by Type
11.1 Introduction
11.2 Custom Synthesis & Conjugation Services
11.2.1 Growing Need for Targeted & Customized Therapies to Drive Market
11.3 Analytical & Characterization Services
11.3.1 Growing Focus on Regulatory Compliance to Fuel Uptake
11.4 Scale-Up & Manufacturing Services
11.4.1 Increasing Commercialization of Bioconjugated Drugs to Support Market Growth
11.5 Other Services
12 Bioconjugation Services Market, by Conjugation Type
12.1 Introduction
12.2 Antibody Conjugation
12.2.1 Ability to Link Antibodies to Payloads for Specialized Therapeutics to Propel Market
12.3 Peptide Conjugation
12.3.1 Improved Stability & Bioavailability to Drive Market
12.4 Protein Conjugation
12.4.1 Linking Proteins with Drugs for Targeted Delivery to Fuel Uptake
12.5 Oligonucleotide Conjugation
12.5.1 Advancements in Nucleic Acid-based Therapeutics to Support Market Growth
12.6 Other Conjugation Services
13 Bioconjugation Services Market, by Technique
13.1 Introduction
13.2 Chemical Conjugation
13.2.1 Essential Technique for Development of Custom Bioconjugates to Fuel Uptake
13.3 Click Chemistry
13.3.1 Provision of High Yield for Development of Complex Bioconjugates to Propel Market
13.4 Enzyme-Mediated Conjugation
13.4.1 Need for Precise & Stable Conjugates in Complex Therapeutic Modalities to Drive Market
13.5 Photoreactive Crosslinking
13.5.1 Ability to Provide Controlled & Site-Specific Formation of Crosslinks to Support Market Growth
13.6 Other Techniques
14 Bioconjugation Services Market, by Application
14.1 Introduction
14.2 Therapeutics
14.2.1 Strategic Partnerships Between Biopharma Companies and Bioconjugation Service Providers to Propel Market
14.3 Research & Development
14.3.1 Growing Focus on Biomolecular Research Innovation to Drive Market
14.4 Diagnostics
14.4.1 Development of Advanced Imaging Technologies and Biosensors to Support Market Growth
15 Bioconjugation Services Market, by End-user
15.1 Introduction
15.2 Pharmaceutical & Biotechnology Companies
15.2.1 Advancements in Drug Discovery & Development to Propel Market
15.3 Academic & Research Institutes
15.3.1 Innovation in Conjugation Techniques and Biomedical Research to Drive Market
15.4 Hospitals and Clinical/Diagnostic Laboratories
15.4.1 Increasing Demand for Precision Diagnostics to Fuel Uptake
16 Bioconjugation Market, by Region
16.1 Introduction
16.2 North America
16.2.1 North America: Macroeconomic Outlook
16.2.2 US
16.2.2.1 High Healthcare Expenditure to Propel Market
16.2.3 Canada
16.2.3.1 Increasing Government Funding for Drug Development to Support Market Growth
16.3 Europe
16.3.1 Europe: Macroeconomic Outlook
16.3.2 Germany
16.3.2.1 Facility Expansion by Key Players to Aid Market Growth
16.3.3 UK
16.3.3.1 Increased Cancer Prevalence and Government Funding for Pharmaceutical & Biotechnology Research to Fuel Uptake
16.3.4 France
16.3.4.1 Favorable Government Initiatives and Growing Demand for Personalized Therapeutics to Boost Demand
16.3.5 Italy
16.3.5.1 Increasing Industrial Collaborations for Adc Production to Support Market Growth
16.3.6 Spain
16.3.6.1 Growing Preference for Personalized Medicine to Drive Market
16.3.7 Rest of Europe
16.4 Asia-Pacific
16.4.1 Asia-Pacific: Macroeconomic Outlook
16.4.2 China
16.4.2.1 Expansion of Biopharmaceutical Manufacturing Facilities to Boost Demand
16.4.3 Japan
16.4.3.1 Increasing Collaborations Among Biotechnology Companies to Support Market Growth
16.4.4 India
16.4.4.1 High Investments in Pharma R&D and Favorable Government Policies to Boost Demand
16.4.5 South Korea
16.4.5.1 Increased Focus on Quality Manufacturing Practices to Propel Market
16.4.6 Australia
16.4.6.1 Growing Demand for Innovative Research Solutions to Drive Market
16.4.7 Rest of Asia-Pacific
16.5 Latin America
16.5.1 Latin America: Macroeconomic Outlook
16.5.2 Brazil
16.5.2.1 Increasing Pharmaceutical R&D to Fuel Market
16.5.3 Mexico
16.5.3.1 High Fdis and Reduced Pharmaceutical Manufacturing Costs to Drive Market
16.5.4 Rest of Latin America
16.6 Middle East
16.6.1 Middle East: Macroeconomic Outlook
16.6.2 GCC Countries
16.6.2.1 Kingdom of Saudi Arabia
16.6.2.1.1 Rising Healthcare Expenditure to Boost Market
16.6.2.2 United Arab Emirates
16.6.2.2.1 Increasing Collaborations Among Biopharma Companies to Aid Market Growth
16.6.2.3 Other GCC Countries
16.6.3 Rest of Middle East
16.7 Africa
16.7.1 Increasing Target Patient Pool to Support Market Growth
16.7.2 Africa: Macroeconomic Outlook
17 Competitive Landscape
17.1 Overview
17.2 Key Player Strategy/Right to Win
17.2.1 Overview of Strategies Adopted by Players in Bioconjugation Market
17.3 Revenue Analysis
17.4 Market Share Analysis
17.5 Company Evaluation Matrix: Key Players, 2023
17.5.1 Stars
17.5.2 Emerging Leaders
17.5.3 Pervasive Players
17.5.4 Participants
17.5.5 Company Footprint: Key Players, 2023
17.5.5.1 Company Footprint
17.5.5.2 Product/Service Footprint
17.5.5.3 Application Footprint
17.5.5.4 End-user Footprint
17.5.5.5 Region Footprint
17.6 Company Evaluation Matrix: Startups/SMEs, 2023
17.6.1 Progressive Companies
17.6.2 Responsive Companies
17.6.3 Dynamic Companies
17.6.4 Starting Blocks
17.6.5 Competitive Benchmarking: Startups/SMEs, 2023
17.7 Company Valuation & Financial Metrics
17.7.1 Financial Metrics
17.7.2 Company Valuation
17.8 Brand/Product/Service Comparison
17.9 Competitive Scenario
17.9.1 Product/Service Launches
17.9.2 Deals
17.9.3 Expansions
18 Company Profiles
18.1 Key Players
18.1.1 Danaher Corporation
18.1.1.1 Business Overview
18.1.1.2 Products/Services Offered
18.1.1.3 Recent Developments
18.1.1.3.1 Product/Service Launches
18.1.1.3.2 Deals
18.1.1.3.3 Expansions
18.1.1.4 Analyst's View
18.1.1.4.1 Key Strengths
18.1.1.4.2 Strategic Choices
18.1.1.4.3 Weaknesses & Competitive Threats
18.1.2 Lonza
18.1.2.1 Business Overview
18.1.2.2 Products/Services Offered
18.1.2.3 Recent Developments
18.1.2.3.1 Deals
18.1.2.3.2 Expansions
18.1.2.4 Analyst's View
18.1.2.4.1 Key Strengths
18.1.2.4.2 Strategic Choices
18.1.2.4.3 Weaknesses & Competitive Threats
18.1.3 Thermo Fisher Scientific Inc.
18.1.3.1 Business Overview
18.1.3.2 Products/Services Offered
18.1.3.3 Recent Developments
18.1.3.3.1 Product/Service Launches
18.1.3.3.2 Deals
18.1.3.3.3 Expansions
18.1.3.4 Analyst's View
18.1.3.4.1 Key Strengths
18.1.3.4.2 Strategic Choices
18.1.3.4.3 Weaknesses & Competitive Threats
18.1.4 Merck KGaA
18.1.4.1 Business Overview
18.1.4.2 Products/Services Offered
18.1.4.3 Recent Developments
18.1.4.3.1 Product/Service Launches
18.1.4.3.2 Deals
18.1.4.3.3 Expansions
18.1.4.4 Analyst's View
18.1.4.4.1 Key Strengths
18.1.4.4.2 Strategic Choices
18.1.4.4.3 Weaknesses & Competitive Threats
18.1.5 Abbvie Inc.
18.1.5.1 Business Overview
18.1.5.2 Products/Services Offered
18.1.5.3 Recent Developments
18.1.5.3.1 Deals
18.1.5.3.2 Expansions
18.1.5.4 Analyst's View
18.1.5.4.1 Key Strengths
18.1.5.4.2 Strategic Choices
18.1.5.4.3 Weaknesses & Competitive Threats
18.1.6 Wuxi Biologics (Cayman) Inc.
18.1.6.1 Business Overview
18.1.6.2 Products/Services Offered
18.1.6.3 Recent Developments
18.1.6.3.1 Deals
18.1.6.3.2 Expansions
18.1.7 Sartorius AG
18.1.7.1 Business Overview
18.1.7.2 Products/Services Offered
18.1.7.3 Recent Developments
18.1.7.3.1 Deals
18.1.7.3.2 Expansions
18.1.8 Bio-Rad Laboratories, Inc.
18.1.8.1 Business Overview
18.1.8.2 Products/Services Offered
18.1.9 Catalent, Inc.
18.1.9.1 Business Overview
18.1.9.2 Products/Services Offered
18.1.9.3 Recent Developments
18.1.9.3.1 Product/Service Launches
18.1.9.3.2 Deals
18.1.9.3.3 Expansions
18.1.10 Beckton, Dickinson and Company
18.1.10.1 Business Overview
18.1.10.2 Products/Services Offered
18.1.10.3 Recent Developments
18.1.10.3.1 Product/Service Launches
18.1.10.3.2 Deals
18.1.11 Agilent Technologies, Inc.
18.1.11.1 Business Overview
18.1.11.2 Products/Services Offered
18.1.11.3 Recent Developments
18.1.11.3.1 Product/Service Launches
18.1.11.3.2 Deals
18.1.11.3.3 Expansions
18.1.12 Promega Corporation
18.1.12.1 Business Overview
18.1.12.2 Products/Services Offered
18.1.13 F. Hoffmann-La Roche Ltd.
18.1.13.1 Business Overview
18.1.13.2 Products/Services Offered
18.1.14 Charles River Laboratories
18.1.14.1 Business Overview
18.1.14.2 Products/Services Offered
18.1.14.3 Recent Developments
18.1.14.3.1 Deals
18.1.15 Genscript Biotech Corporation
18.1.15.1 Business Overview
18.1.15.2 Products/Services Offered
18.1.15.3 Recent Developments
18.1.15.3.1 Deals
18.1.16 Piramal Pharma Limited
18.1.16.1 Business Overview
18.1.16.2 Products/Services Offered
18.1.16.3 Recent Developments
18.1.16.3.1 Product/Service Launches
18.1.16.3.2 Expansions
18.2 Other Players
18.2.1 Abzena Ltd.
18.2.2 New England Biolabs
18.2.3 Biosynth
18.2.4 Cell Signaling Technology, Inc.
18.2.5 Creative Biolabs
18.2.6 Formosa Laboratories Inc.
18.2.7 Nj Bio, Inc.
18.2.8 Rockland Immunochemicals, Inc.
18.2.9 Shanghai Chempartner
18.2.10 Sterling Pharma Solutions Limited
18.2.11 Syngene International Limited
18.2.12 Tokyo Chemical Industry Co. Ltd.
18.2.13 Vector Laboratories, Inc.
19 Appendix
19.1 Discussion Guide
19.2 Knowledgestore: The Subscription Portal
19.3 Customization Options
List of Tables
Table 1 Bioconjugation Market: Inclusions & Exclusions
Table 2 Impact Analysis of Supply-Side and Demand-Side Factors
Table 3 Bioconjugation Market: Risk Assessment Analysis
Table 4 Bioconjugation Market: Impact Analysis
Table 5 List of Key Site-Specific Conjugation Technologies (Engineered Reactive Cysteines/ Cysteine Conjugation)
Table 6 Indicative Product Pricing Analysis, by Key Player (2023)
Table 7 Indicative Pricing Analysis of Bioconjugation Products, by Region (2023)
Table 8 Bioconjugation Market: Raw Material Suppliers
Table 9 Bioconjugation Market: Product Manufacturers
Table 10 Bioconjugation Market: Service Providers
Table 11 Bioconjugation Market: End-users
Table 12 Bioconjugation Market: Regulatory Bodies
Table 13 Bioconjugation: Complementary Technologies
Table 14 Bioconjugation: Adjacent Technologies
Table 15 Key Patents in Bioconjugation Market
Table 16 Bioconjugation Market: Key Conferences & Events, 2024-2025
Table 17 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 18 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 19 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 20 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 21 Middle East & Africa: Regulatory Bodies, Government Agencies, and Other Organizations
Table 22 List of Antibody-Drug Conjugate Venture Capital Funding Events and Ipos.
Table 23 Bioconjugation Market: Porter's Five Forces Analysis
Table 24 Key Buying Criteria for Bioconjugation Products, by End-user
Table 25 Import Value for HS Code 9027, 2019-2023 (USD Thousand)
Table 26 Export Value for HS Code 9027, 2019-2023 (USD Thousand)
Table 27 Import Volume for HS Code 9027, 2019-2023 (Tons)
Table 28 Export Volume for HS Code 9027, 2019-2023 (Tons)
Table 29 Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 30 Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 31 Bioconjugation Consumables Market, by Region, 2022-2029 (USD Million)
Table 32 North America: Bioconjugation Consumables Market, by Country, 2022-2029 (USD Million)
Table 33 Europe: Bioconjugation Consumables Market, by Country, 2022-2029 (USD Million)
Table 34 Asia-Pacific: Bioconjugation Consumables Market, by Country, 2022-2029 (USD Million)
Table 35 Latin America: Bioconjugation Consumables Market, by Country, 2022-2029 (USD Million)
Table 36 Middle East: Bioconjugation Consumables Market, by Region, 2022-2029 (USD Million)
Table 37 GCC Countries: Bioconjugation Consumables Market, by Country, 2022-2029 (USD Million)
Table 38 Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 39 Bioconjugation Reagents & Kits Market, by Region, 2022-2029 (USD Million)
Table 40 North America: Bioconjugation Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 41 Europe: Bioconjugation Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 42 Asia-Pacific: Bioconjugation Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 43 Latin America: Bioconjugation Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 44 Middle East: Bioconjugation Reagents & Kits Market, by Region, 2022-2029 (USD Million)
Table 45 GCC Countries: Bioconjugation Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 46 Bioconjugation Linker and Crosslinking Reagents & Kits Market, By Region, 2022-2029 (USD Million)
Table 47 North America: Bioconjugation Linker and Crosslinking Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 48 Europe: Bioconjugation Linker and Crosslinking Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 49 Asia-Pacific: Bioconjugation Linker and Crosslinking Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 50 Latin America: Bioconjugation Linker and Crosslinking Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 51 Middle East: Bioconjugation Linker and Crosslinking Reagents & Kits Market, by Region, 2022-2029 (USD Million)
Table 52 GCC Countries: Bioconjugation Linker and Crosslinking Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 53 Bioconjugation Labeling Reagents & Kits Market, by Region, 2022-2029 (USD Million)
Table 54 North America: Bioconjugation Labeling Reagents & Kits Market, By Country, 2022-2029 (USD Million)
Table 55 Europe: Bioconjugation Labeling Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 56 Asia-Pacific: Bioconjugation Labeling Reagents & Kits Market, By Country, 2022-2029 (USD Million)
Table 57 Latin America: Bioconjugation Labeling Reagents & Kits Market, By Country, 2022-2029 (USD Million)
Table 58 Middle East: Bioconjugation Labeling Reagents & Kits Market, By Region, 2022-2029 (USD Million)
Table 59 GCC Countries: Bioconjugation Labeling Reagents & Kits Market, By Country, 2022-2029 (USD Million)
Table 60 Bioconjugation Modification Reagents & Kits Market, by Region, 2022-2029 (USD Million)
Table 61 North America: Bioconjugation Modification Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 62 Europe: Bioconjugation Modification Reagents & Kits Market, By Country, 2022-2029 (USD Million)
Table 63 Asia-Pacific: Bioconjugation Modification Reagents & Kits Market, By Country, 2022-2029 (USD Million)
Table 64 Latin America: Bioconjugation Modification Reagents & Kits Market, By Country, 2022-2029 (USD Million)
Table 65 Middle East: Bioconjugation Modification Reagents & Kits Market, By Region, 2022-2029 (USD Million)
Table 66 GCC Countries: Bioconjugation Modification Reagents & Kits Market, By Country, 2022-2029 (USD Million)
Table 67 Other Bioconjugation Reagents & Kits Market, by Region, 2022-2029 (USD Million)
Table 68 North America: Other Bioconjugation Reagents & Kits Market, By Country, 2022-2029 (USD Million)
Table 69 Europe: Other Bioconjugation Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 70 Asia-Pacific: Other Bioconjugation Reagents & Kits Market, by Country, 2022-2029 (USD Million)
Table 71 Latin America: Other Bioconjugation Reagents & Kits Market, By Country, 2022-2029 (USD Million)
Table 72 Middle East: Other Bioconjugation Reagents & Kits Market, by Region, 2022-2029 (USD Million)
Table 73 GCC Countries: Other Bioconjugation Reagents & Kits Market, By Country, 2022-2029 (USD Million)
Table 74 Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 75 Bioconjugation Labels Market, by Region, 2022-2029 (USD Million)
Table 76 North America: Bioconjugation Labels Market, by Country, 2022-2029 (USD Million)
Table 77 Europe: Bioconjugation Labels Market, by Country, 2022-2029 (USD Million)
Table 78 Asia-Pacific: Bioconjugation Labels Market, by Country, 2022-2029 (USD Million)
Table 79 Latin America: Bioconjugation Labels Market, by Country, 2022-2029 (USD Million)
Table 80 Middle East: Bioconjugation Labels Market, by Region, 2022-2029 (USD Million)
Table 81 GCC Countries: Bioconjugation Labels Market, by Country, 2022-2029 (USD Million)
Table 82 Bioconjugation Labels Market for Fluorescent Tags, by Region, 2022-2029 (USD Million)
Table 83 North America: Bioconjugation Labels Market for Fluorescent Tags, by Country, 2022-2029 (USD Million)
Table 84 Europe: Bioconjugation Labels Market for Fluorescent Tags, By Country, 2022-2029 (USD Million)
Table 85 Asia-Pacific: Bioconjugation Labels Market for Fluorescent Tags, By Country, 2022-2029 (USD Million)
Table 86 Latin America: Bioconjugation Labels Market for Fluorescent Tags, By Country, 2022-2029 (USD Million)
Table 87 Middle East: Bioconjugation Labels Market for Fluorescent Tags, By Region, 2022-2029 (USD Million)
Table 88 GCC Countries: Bioconjugation Labels Market for Fluorescent Tags, By Country, 2022-2029 (USD Million)
Table 89 Bioconjugation Labels Market for Enzymes, by Region, 2022-2029 (USD Million)
Table 90 North America: Bioconjugation Labels Market for Enzymes, By Country, 2022-2029 (USD Million)
Table 91 Europe: Bioconjugation Labels Market for Enzymes, by Country, 2022-2029 (USD Million)
Table 92 Asia-Pacific: Bioconjugation Labels Market for Enzymes, by Country, 2022-2029 (USD Million)
Table 93 Latin America: Bioconjugation Labels Market for Enzymes, by Country, 2022-2029 (USD Million)
Table 94 Middle East: Bioconjugation Labels Market for Enzymes, by Region, 2022-2029 (USD Million)
Table 95 GCC Countries: Bioconjugation Labels Market for Enzymes, by Country, 2022-2029 (USD Million)
Table 96 Bioconjugation Labels Market for Haptens, by Region, 2022-2029 (USD Million)
Table 97 North America: Bioconjugation Labels Market for Haptens, by Country, 2022-2029 (USD Million)
Table 98 Europe: Bioconjugation Labels Market for Haptens, by Country, 2022-2029 (USD Million)
Table 99 Asia-Pacific: Bioconjugation Labels Market for Haptens, by Country, 2022-2029 (USD Million)
Table 100 Latin America: Bioconjugation Labels Market for Haptens, by Country, 2022-2029 (USD Million)
Table 101 Middle East: Bioconjugation Labels Market for Haptens, by Region, 2022-2029 (USD Million)
Table 102 GCC Countries: Bioconjugation Labels Market for Haptens, by Country, 2022-2029 (USD Million)
Table 103 Bioconjugation Labels Market for Polymers, by Region, 2022-2029 (USD Million)
Table 104 North America: Bioconjugation Labels Market for Polymers, By Country, 2022-2029 (USD Million)
Table 105 Europe: Bioconjugation Labels Market for Polymers, by Country, 2022-2029 (USD Million)
Table 106 Asia-Pacific: Bioconjugation Labels Market for Polymers, by Country, 2022-2029 (USD Million)
Table 107 Latin America: Bioconjugation Labels Market for Polymers, By Country, 2022-2029 (USD Million)
Table 108 Middle East: Bioconjugation Labels Market for Polymers, by Region, 2022-2029 (USD Million)
Table 109 GCC Countries: Bioconjugation Labels Market for Polymers, By Country, 2022-2029 (USD Million)
Table 110 Bioconjugation Labels Market for Bead Coupling, by Region, 2022-2029 (USD Million)
Table 111 North America: Bioconjugation Labels Market for Bead Coupling, By Country, 2022-2029 (USD Million)
Table 112 Europe: Bioconjugation Labels Market for Bead Coupling, by Country, 2022-2029 (USD Million)
Table 113 Asia-Pacific: Bioconjugation Labels Market for Bead Coupling, By Country, 2022-2029 (USD Million)
Table 114 Latin America: Bioconjugation Labels Market for Bead Coupling, By Country, 2022-2029 (USD Million)
Table 115 Middle East: Bioconjugation Labels Market for Bead Coupling, By Region, 2022-2029 (USD Million)
Table 116 GCC Countries: Bioconjugation Labels Market for Bead Coupling, By Country, 2022-2029 (USD Million)
Table 117 Other Bioconjugation Labels Market, by Region, 2022-2029 (USD Million)
Table 118 North America: Other Bioconjugation Labels Market, by Country, 2022-2029 (USD Million)
Table 119 Europe: Other Bioconjugation Labels Market, by Country, 2022-2029 (USD Million)
Table 120 Asia-Pacific: Other Bioconjugation Labels Market, by Country, 2022-2029 (USD Million)
Table 121 Latin America: Other Bioconjugation Labels Market, by Country, 2022-2029 (USD Million)
Table 122 Middle East: Other Bioconjugation Labels Market, by Region, 2022-2029 (USD Million)
Table 123 GCC Countries: Other Bioconjugation Labels Market, by Country, 2022-2029 (USD Million)
Table 124 Other Bioconjugation Consumables Market, by Region, 2022-2029 (USD Million)
Table 125 North America: Other Bioconjugation Consumables Market, By Country, 2022-2029 (USD Million)
Table 126 Europe: Other Bioconjugation Consumables Market, by Country, 2022-2029 (USD Million)
Table 127 Asia-Pacific: Other Bioconjugation Consumables Market, by Country, 2022-2029 (USD Million)
Table 128 Latin America: Other Bioconjugation Consumables Market, by Country, 2022-2029 (USD Million)
Table 129 Middle East: Other Bioconjugation Consumables Market, by Region, 2022-2029 (USD Million)
Table 130 GCC Countries: Other Bioconjugation Consumables Market, By Country, 2022-2029 (USD Million)
Table 131 Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 132 Bioconjugation Instruments Market, by Region, 2022-2029 (USD Million)
Table 133 North America: Bioconjugation Instruments Market, by Country, 2022-2029 (USD Million)
Table 134 Europe: Bioconjugation Instruments Market, by Country, 2022-2029 (USD Million)
Table 135 Asia-Pacific: Bioconjugation Instruments Market, by Country, 2022-2029 (USD Million)
Table 136 Latin America: Bioconjugation Instruments Market, by Country, 2022-2029 (USD Million)
Table 137 Middle East: Bioconjugation Instruments Market, by Region, 2022-2029 (USD Million)
Table 138 GCC Countries: Bioconjugation Instruments Market, by Country, 2022-2029 (USD Million)
Table 139 Chromatography Systems Market, by Region, 2022-2029 (USD Million)
Table 140 North America: Chromatography Systems Market, by Country, 2022-2029 (USD Million)
Table 141 Europe: Chromatography Systems Market, by Country, 2022-2029 (USD Million)
Table 142 Asia-Pacific: Chromatography Systems Market, by Country, 2022-2029 (USD Million)
Table 143 Latin America: Chromatography Systems Market, by Country, 2022-2029 (USD Million)
Table 144 Middle East: Chromatography Systems Market, by Region, 2022-2029 (USD Million)
Table 145 GCC Countries: Chromatography Systems Market, by Country, 2022-2029 (USD Million)
Table 146 Mass Spectrometers Market, by Region, 2022-2029 (USD Million)
Table 147 North America: Mass Spectrometers Market, by Country, 2022-2029 (USD Million)
Table 148 Europe: Mass Spectrometers Market, by Country, 2022-2029 (USD Million)
Table 149 Asia-Pacific: Mass Spectrometers Market, by Country, 2022-2029 (USD Million)
Table 150 Latin America: Mass Spectrometers Market, by Country, 2022-2029 (USD Million)
Table 151 Middle East: Mass Spectrometers Market, by Region, 2022-2029 (USD Million)
Table 152 GCC Countries: Mass Spectrometers Market, by Country, 2022-2029 (USD Million)
Table 153 Spectroscopy Instruments Market, by Region, 2022-2029 (USD Million)
Table 154 North America: Spectroscopy Instruments Market, by Country, 2022-2029 (USD Million)
Table 155 Europe: Spectroscopy Instruments Market, by Country, 2022-2029 (USD Million)
Table 156 Asia-Pacific: Spectroscopy Instruments Market, by Country, 2022-2029 (USD Million)
Table 157 Latin America: Spectroscopy Instruments Market, by Country, 2022-2029 (USD Million)
Table 158 Middle East: Spectroscopy Instruments Market, by Region, 2022-2029 (USD Million)
Table 159 GCC Countries: Spectroscopy Instruments Market, by Country, 2022-2029 (USD Million)
Table 160 Flow Cytometers Market, by Region, 2022-2029 (USD Million)
Table 161 North America: Flow Cytometers Market, by Country, 2022-2029 (USD Million)
Table 162 Europe: Flow Cytometers Market, by Country, 2022-2029 (USD Million)
Table 163 Asia-Pacific: Flow Cytometers Market, by Country, 2022-2029 (USD Million)
Table 164 Latin America: Flow Cytometers Market, by Country, 2022-2029 (USD Million)
Table 165 Middle East: Flow Cytometers Market, by Region, 2022-2029 (USD Million)
Table 166 GCC Countries: Flow Cytometers Market, by Country, 2022-2029 (USD Million)
Table 167 Electrophoresis Equipment Market, by Region, 2022-2029 (USD Million)
Table 168 North America: Electrophoresis Equipment Market, by Country, 2022-2029 (USD Million)
Table 169 Europe: Electrophoresis Equipment Market, by Country, 2022-2029 (USD Million)
Table 170 Asia-Pacific: Electrophoresis Equipment Market, by Country, 2022-2029 (USD Million)
Table 171 Latin America: Electrophoresis Equipment Market, by Country, 2022-2029 (USD Million)
Table 172 Middle East: Electrophoresis Equipment Market, by Region, 2022-2029 (USD Million)
Table 173 GCC Countries: Electrophoresis Equipment Market, by Country, 2022-2029 (USD Million)
Table 174 Filtration Systems Market, by Region, 2022-2029 (USD Million)
Table 175 North America: Filtration Systems Market, by Country, 2022-2029 (USD Million)
Table 176 Europe: Filtration Systems Market, by Country, 2022-2029 (USD Million)
Table 177 Asia-Pacific: Filtration Systems Market, by Country, 2022-2029 (USD Million)
Table 178 Latin America: Filtration Systems Market, by Country, 2022-2029 (USD Million)
Table 179 Middle East: Filtration Systems Market, by Region, 2022-2029 (USD Million)
Table 180 GCC Countries: Filtration Systems Market, by Country, 2022-2029 (USD Million)
Table 181 Mixers & Shakers Market, by Region, 2022-2029 (USD Million)
Table 182 North America: Mixers & Shakers Market, by Country, 2022-2029 (USD Million)
Table 183 Europe: Mixers & Shakers Market, by Country, 2022-2029 (USD Million)
Table 184 Asia-Pacific: Mixers & Shakers Market, by Country, 2022-2029 (USD Million)
Table 185 Latin America: Mixers & Shakers Market, by Country, 2022-2029 (USD Million)
Table 186 Middle East: Mixers & Shakers Market, by Region, 2022-2029 (USD Million)
Table 187 GCC Countries: Mixers & Shakers Market, by Country, 2022-2029 (USD Million)
Table 188 Incubators Market, by Region, 2022-2029 (USD Million)
Table 189 North America: Incubators Market, by Country, 2022-2029 (USD Million)
Table 190 Europe: Incubators Market, by Country, 2022-2029 (USD Million)
Table 191 Asia-Pacific: Incubators Market, by Country, 2022-2029 (USD Million)
Table 192 Latin America: Incubators Market, by Country, 2022-2029 (USD Million)
Table 193 Middle East: Incubators Market, by Region, 2022-2029 (USD Million)
Table 194 GCC Countries: Incubators Market, by Country, 2022-2029 (USD Million)
Table 195 Other Bioconjugation Instruments Market, by Region, 2022-2029 (USD Million)
Table 196 North America: Other Bioconjugation Instruments Market, by Country, 2022-2029 (USD Million)
Table 197 Europe: Other Bioconjugation Instruments Market, by Country, 2022-2029 (USD Million)
Table 198 Asia-Pacific: Other Bioconjugation Instruments Market, by Country, 2022-2029 (USD Million)
Table 199 Latin America: Other Bioconjugation Instruments Market, by Country, 2022-2029 (USD Million)
Table 200 Middle East: Other Bioconjugation Instruments Market, by Region, 2022-2029 (USD Million)
Table 201 GCC Countries: Other Bioconjugation Instruments Market, by Country, 2022-2029 (USD Million)
Table 202 Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 203 Bioconjugation Products Market for Chemical Conjugation, by Region, 2022-2029 (USD Million)
Table 204 North America: Bioconjugation Products Market for Chemical Conjugation, by Country, 2022-2029 (USD Million)
Table 205 Europe: Bioconjugation Products Market for Chemical Conjugation, By Country, 2022-2029 (USD Million)
Table 206 Asia-Pacific: Bioconjugation Products Market for Chemical Conjugation, by Country, 2022-2029 (USD Million)
Table 207 Latin America: Bioconjugation Products Market for Chemical Conjugation, by Country, 2022-2029 (USD Million)
Table 208 Middle East: Bioconjugation Products Market for Chemical Conjugation, by Region, 2022-2029 (USD Million)
Table 209 GCC Countries: Bioconjugation Products Market for Chemical Conjugation, by Country, 2022-2029 (USD Million)
Table 210 Application of Copper-Catalyzed Azide-Alkyne Cycloaddition Reaction in Synthesis of Antibody-Drug Conjugates
Table 211 Bioconjugation Products Market for Click Chemistry, by Region, 2022-2029 (USD Million)
Table 212 North America: Bioconjugation Products Market for Click Chemistry, by Country, 2022-2029 (USD Million)
Table 213 Europe: Bioconjugation Products Market for Click Chemistry, By Country, 2022-2029 (USD Million)
Table 214 Asia-Pacific: Bioconjugation Products Market for Click Chemistry, By Country, 2022-2029 (USD Million)
Table 215 Latin America: Bioconjugation Products Market for Click Chemistry, By Country, 2022-2029 (USD Million)
Table 216 Middle East: Bioconjugation Products Market for Click Chemistry, By Region, 2022-2029 (USD Million)
Table 217 GCC Countries: Bioconjugation Products Market for Click Chemistry, by Country, 2022-2029 (USD Million)
Table 218 Bioconjugation Products Market for Enzyme-Mediated Conjugation, By Region, 2022-2029 (USD Million)
Table 219 North America: Bioconjugation Products Market for Enzyme-Mediated Conjugation, by Country, 2022-2029 (USD Million)
Table 220 Europe: Bioconjugation Products Market for Enzyme-Mediated Conjugation, by Country, 2022-2029 (USD Million)
Table 221 Asia-Pacific: Bioconjugation Products Market for Enzyme-Mediated Conjugation, by Country, 2022-2029 (USD Million)
Table 222 Latin America: Bioconjugation Products Market for Enzyme-Mediated Conjugation, by Country, 2022-2029 (USD Million)
Table 223 Middle East: Bioconjugation Products Market for Enzyme-Mediated Conjugation, by Region, 2022-2029 (USD Million)
Table 224 GCC Countries: Bioconjugation Products Market for Enzyme-Mediated Conjugation, by Country, 2022-2029 (USD Million)
Table 225 Bioconjugation Products Market for Photoreactive Crosslinking, By Region, 2022-2029 (USD Million)
Table 226 North America: Bioconjugation Products Market for Photoreactive Crosslinking, by Country, 2022-2029 (USD Million)
Table 227 Europe: Bioconjugation Products Market for Photoreactive Crosslinking, by Country, 2022-2029 (USD Million)
Table 228 Asia-Pacific: Bioconjugation Products Market for Photoreactive Crosslinking, by Country, 2022-2029 (USD Million)
Table 229 Latin America: Bioconjugation Products Market for Photoreactive Crosslinking, by Country, 2022-2029 (USD Million)
Table 230 Middle East: Bioconjugation Products Market for Photoreactive Crosslinking, by Region, 2022-2029 (USD Million)
Table 231 GCC Countries: Bioconjugation Products Market for Photoreactive Crosslinking, by Country, 2022-2029 (USD Million)
Table 232 Bioconjugation Products Market for Other Techniques, by Region, 2022-2029 (USD Million)
Table 233 North America: Bioconjugation Products Market for Other Techniques, by Country, 2022-2029 (USD Million)
Table 234 Europe: Bioconjugation Products Market for Other Techniques, By Country, 2022-2029 (USD Million)
Table 235 Asia-Pacific: Bioconjugation Products Market for Other Techniques, By Country, 2022-2029 (USD Million)
Table 236 Latin America: Bioconjugation Products Market for Other Techniques, by Country, 2022-2029 (USD Million)
Table 237 Middle East: Bioconjugation Products Market for Other Techniques, by Region, 2022-2029 (USD Million)
Table 238 GCC Countries: Bioconjugation Products Market for Other Techniques, by Country, 2022-2029 (USD Million)
Table 239 Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 240 Bioconjugation Products Market for Antibodies, by Region, 2022-2029 (USD Million)
Table 241 North America: Bioconjugation Products Market for Antibodies, By Country, 2022-2029 (USD Million)
Table 242 Europe: Bioconjugation Products Market for Antibodies, by Country, 2022-2029 (USD Million)
Table 243 Asia-Pacific: Bioconjugation Products Market for Antibodies, By Country, 2022-2029 (USD Million)
Table 244 Latin America: Bioconjugation Products Market for Antibodies, By Country, 2022-2029 (USD Million)
Table 245 Middle East: Bioconjugation Products Market for Antibodies, By Region, 2022-2029 (USD Million)
Table 246 GCC Countries: Bioconjugation Products Market for Antibodies, By Country, 2022-2029 (USD Million)
Table 247 Bioconjugation Products Market for Peptides, by Region, 2022-2029 (USD Million)
Table 248 North America: Bioconjugation Products Market for Peptides, By Country, 2022-2029 (USD Million)
Table 249 Europe: Bioconjugation Products Market for Peptides, by Country, 2022-2029 (USD Million)
Table 250 Asia-Pacific: Bioconjugation Products Market for Peptides, by Country, 2022-2029 (USD Million)
Table 251 Latin America: Bioconjugation Products Market for Peptides, By Country, 2022-2029 (USD Million)
Table 252 Middle East: Bioconjugation Products Market for Peptides, by Region, 2022-2029 (USD Million)
Table 253 GCC Countries: Bioconjugation Products Market for Peptides, By Country, 2022-2029 (USD Million)
Table 254 Bioconjugation Products Market for Proteins, by Region, 2022-2029 (USD Million)
Table 255 North America: Bioconjugation Products Market for Proteins, By Country, 2022-2029 (USD Million)
Table 256 Europe: Bioconjugation Products Market for Proteins, by Country, 2022-2029 (USD Million)
Table 257 Asia-Pacific: Bioconjugation Products Market for Proteins, by Country, 2022-2029 (USD Million)
Table 258 Latin America: Bioconjugation Products Market for Proteins, By Country, 2022-2029 (USD Million)
Table 259 Middle East: Bioconjugation Products Market for Proteins, by Region, 2022-2029 (USD Million)
Table 260 GCC Countries: Bioconjugation Products Market for Proteins, By Country, 2022-2029 (USD Million)
Table 261 Bioconjugation Products Market for Oligonucleotides, by Region, 2022-2029 (USD Million)
Table 262 North America: Bioconjugation Products Market for Oligonucleotides, by Country, 2022-2029 (USD Million)
Table 263 Europe: Bioconjugation Products Market for Oligonucleotides, By Country, 2022-2029 (USD Million)
Table 264 Asia-Pacific: Bioconjugation Products Market for Oligonucleotides, By Country, 2022-2029 (USD Million)
Table 265 Latin America: Bioconjugation Products Market for Oligonucleotides, by Country, 2022-2029 (USD Million)
Table 266 Middle East: Bioconjugation Products Market for Oligonucleotides, by Region, 2022-2029 (USD Million)
Table 267 GCC Countries: Bioconjugation Products Market for Oligonucleotides, by Country, 2022-2029 (USD Million)
Table 268 Bioconjugation Products Market for Other Biomolecules, by Region, 2022-2029 (USD Million)
Table 269 North America: Bioconjugation Products Market for Other Biomolecules, by Country, 2022-2029 (USD Million)
Table 270 Europe: Bioconjugation Products Market for Other Biomolecules, By Country, 2022-2029 (USD Million)
Table 271 Asia-Pacific: Bioconjugation Products Market for Other Biomolecules, by Country, 2022-2029 (USD Million)
Table 272 Latin America: Bioconjugation Products Market for Other Biomolecules, by Country, 2022-2029 (USD Million)
Table 273 Middle East: Bioconjugation Products Market for Other Biomolecules, by Region, 2022-2029 (USD Million)
Table 274 GCC Countries: Bioconjugation Products Market for Other Biomolecules, by Country, 2022-2029 (USD Million)
Table 275 Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 276 Fda-Approved Adc Drugs
Table 277 Bioconjugation Products Market for Therapeutic Applications, By Type, 2022-2029 (USD Million)
Table 278 Bioconjugation Products Market for Therapeutic Applications, By Region, 2022-2029 (USD Million)
Table 279 North America: Bioconjugation Products Market for Therapeutic Applications, by Country, 2022-2029 (USD Million)
Table 280 Europe: Bioconjugation Products Market for Therapeutic Applications, by Country, 2022-2029 (USD Million)
Table 281 Asia-Pacific: Bioconjugation Products Market for Therapeutic Applications, by Country, 2022-2029 (USD Million)
Table 282 Latin America: Bioconjugation Products Market for Therapeutic Applications, by Country, 2022-2029 (USD Million)
Table 283 Middle East: Bioconjugation Products Market for Therapeutic Applications, by Region, 2022-2029 (USD Million)
Table 284 GCC Countries: Bioconjugation Products Market for Therapeutic Applications, by Country, 2022-2029 (USD Million)
Table 285 Therapeutic Applications Market for Antibody-Drug Conjugates, By Region, 2022-2029 (USD Million)
Table 286 North America: Therapeutics Applications Market for Antibody-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 287 Europe: Therapeutics Applications Market for Antibody-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 288 Asia-Pacific: Therapeutic Applications Market for Antibody-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 289 Latin America: Therapeutic Applications Market for Antibody-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 290 Middle East: Therapeutic Applications Market for Antibody-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 291 GCC Countries: Therapeutic Applications Market for Antibody-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 292 Comparison of Pdc and Adc
Table 293 Therapeutic Applications Market for Peptide-Drug Conjugates, By Region, 2022-2029 (USD Million)
Table 294 North America: Therapeutic Applications Market for Peptide-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 295 Europe: Therapeutic Applications Market for Peptide-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 296 Asia-Pacific: Therapeutic Applications Market for Peptide-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 297 Latin America: Therapeutic Applications Market for Peptide-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 298 Middle East: Therapeutic Applications Market for Peptide-Drug Conjugates, by Region, 2022-2029 (USD Million)
Table 299 GCC Countries: Therapeutic Applications Market for Peptide-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 300 Therapeutic Applications Market for Protein-Drug Conjugates, By Region, 2022-2029 (USD Million)
Table 301 North America: Therapeutic Applications Market for Protein-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 302 Europe: Therapeutic Applications Market for Protein-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 303 Asia-Pacific: Therapeutic Applications Market for Protein-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 304 Latin America: Therapeutic Applications Market for Protein-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 305 Middle East: Therapeutic Applications Market for Protein-Drug Conjugates, by Region, 2022-2029 (USD Million)
Table 306 GCC Countries: Therapeutic Applications Market for Protein-Drug Conjugates, by Country, 2022-2029 (USD Million)
Table 307 Other Therapeutic Applications Market, by Region, 2022-2029 (USD Million)
Table 308 North America: Other Therapeutic Applications Market, by Country, 2022-2029 (USD Million)
Table 309 Europe: Other Therapeutic Applications Market, by Country, 2022-2029 (USD Million)
Table 310 Asia-Pacific: Other Therapeutic Applications Market, by Country, 2022-2029 (USD Million)
Table 311 Latin America: Other Therapeutic Applications Market, by Country, 2022-2029 (USD Million)
Table 312 Middle East: Other Therapeutic Applications Market, by Region, 2022-2029 (USD Million)
Table 313 GCC Countries: Other Therapeutic Applications Market, by Country, 2022-2029 (USD Million)
Table 314 Bioconjugation Products Market for Research & Development Applications, by Region, 2022-2029 (USD Million)
Table 315 North America: Bioconjugation Products Market for Research & Development Applications, by Country, 2022-2029 (USD Million)
Table 316 Europe: Bioconjugation Products Market for Research & Development Applications, by Country, 2022-2029 (USD Million)
Table 317 Asia-Pacific: Bioconjugation Products Market for Research & Development Applications, by Country, 2022-2029 (USD Million)
Table 318 Latin America: Bioconjugation Products Market for Research & Development Applications, by Country, 2022-2029 (USD Million)
Table 319 Middle East: Bioconjugation Products Market for Research & Development Applications, by Region, 2022-2029 (USD Million)
Table 320 GCC Countries: Bioconjugation Products Market for Research & Development Applications, by Country, 2022-2029 (USD Million)
Table 321 Bioconjugation Products Market for Diagnostic Applications, By Region, 2022-2029 (USD Million)
Table 322 North America: Bioconjugation Products Market for Diagnostic Applications, by Country, 2022-2029 (USD Million)
Table 323 Europe: Bioconjugation Products Market for Diagnostic Applications, by Country, 2022-2029 (USD Million)
Table 324 Asia-Pacific: Bioconjugation Products Market for Diagnostic Applications, by Country, 2022-2029 (USD Million)
Table 325 Latin America: Bioconjugation Products Market for Diagnostic Applications, by Country, 2022-2029 (USD Million)
Table 326 Middle East: Bioconjugation Products Market for Diagnostic Applications, by Region, 2022-2029 (USD Million)
Table 327 GCC Countries: Bioconjugation Products Market for Diagnostic Applications, by Country, 2022-2029 (USD Million)
Table 328 Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 329 Bioconjugation Products Market for Pharmaceutical & Biotechnology Companies, by Region, 2022-2029 (USD Million)
Table 330 North America: Bioconjugation Products Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 331 Europe: Bioconjugation Products Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 332 Asia-Pacific: Bioconjugation Products Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 333 Latin America: Bioconjugation Products Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 334 Middle East: Bioconjugation Products Market for Pharmaceutical & Biotechnology Companies, by Region, 2022-2029 (USD Million)
Table 335 GCC Countries: Bioconjugation Products Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 336 Bioconjugation Products Market for Cros & Cmos, by Region, 2022-2029 (USD Million)
Table 337 North America: Bioconjugation Products Market for Cros & Cmos, By Country, 2022-2029 (USD Million)
Table 338 Europe: Bioconjugation Products Market for Cros & Cmos, by Country, 2022-2029 (USD Million)
Table 339 Asia-Pacific: Bioconjugation Products Market for Cros & Cmos, By Country, 2022-2029 (USD Million)
Table 340 Latin America: Bioconjugation Products Market for Cros & Cmos, By Country, 2022-2029 (USD Million)
Table 341 Middle East: Bioconjugation Products Market for Cros & Cmos, By Region, 2022-2029 (USD Million)
Table 342 GCC Countries: Bioconjugation Products Market for Cros & Cmos, By Country, 2022-2029 (USD Million)
Table 343 Bioconjugation Products Market for Academic & Research Institutes, by Region, 2022-2029 (USD Million)
Table 344 North America: Bioconjugation Products Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 345 Europe: Bioconjugation Products Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 346 Asia-Pacific: Bioconjugation Products Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 347 Latin America: Bioconjugation Products Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 348 Middle East: Bioconjugation Products Market for Academic & Research Institutes, by Region, 2022-2029 (USD Million)
Table 349 GCC Countries: Bioconjugation Products Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 350 Bioconjugation Products Market for Hospitals and Clinical/Diagnostic Laboratories, by Region, 2022-2029 (USD Million)
Table 351 North America: Bioconjugation Products Market for Hospitals and Clinical/Diagnostic Laboratories, by Country, 2022-2029 (USD Million)
Table 352 Europe: Bioconjugation Products Market for Hospitals and Clinical/Diagnostic Laboratories, by Country, 2022-2029 (USD Million)
Table 353 Asia-Pacific: Bioconjugation Products Market for Hospitals and Clinical/Diagnostic Laboratories, by Country, 2022-2029 (USD Million)
Table 354 Latin America: Bioconjugation Products Market for Hospitals and Clinical/Diagnostic Laboratories, by Country, 2022-2029 (USD Million)
Table 355 Middle East: Bioconjugation Products Market for Hospitals and Clinical/Diagnostic Laboratories, by Region, 2022-2029 (USD Million)
Table 356 GCC Countries: Bioconjugation Products Market for Hospitals and Clinical/Diagnostic Laboratories, by Country, 2022-2029 (USD Million)
Table 357 Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 358 Bioconjugation Custom Synthesis & Conjugation Services Market, By Region, 2022-2029 (USD Million)
Table 359 North America: Bioconjugation Custom Synthesis & Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 360 Europe: Bioconjugation Custom Synthesis & Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 361 Asia-Pacific: Bioconjugation Custom Synthesis & Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 362 Latin America: Bioconjugation Custom Synthesis & Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 363 Middle East: Bioconjugation Custom Synthesis & Conjugation Services Market, by Region, 2022-2029 (USD Million)
Table 364 GCC Countries: Bioconjugation Custom Synthesis & Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 365 Key Bioconjugation Characterization Techniques
Table 366 Bioconjugation Analytical & Characterization Services Market, By Region, 2022-2029 (USD Million)
Table 367 North America: Bioconjugation Analytical & Characterization Services Market, by Country, 2022-2029 (USD Million)
Table 368 Europe: Bioconjugation Analytical & Characterization Services Market, by Country, 2022-2029 (USD Million)
Table 369 Asia-Pacific: Bioconjugation Analytical & Characterization Services Market, by Country, 2022-2029 (USD Million)
Table 370 Latin America: Bioconjugation Analytical & Characterization Services Market, by Country, 2022-2029 (USD Million)
Table 371 Middle East: Bioconjugation Analytical & Characterization Services Market, by Region, 2022-2029 (USD Million)
Table 372 GCC Countries: Bioconjugation Analytical & Characterization Services Market, by Country, 2022-2029 (USD Million)
Table 373 Bioconjugation Scale-Up & Manufacturing Services Market, by Region, 2022-2029 (USD Million)
Table 374 North America: Bioconjugation Scale-Up & Manufacturing Services Market, by Country, 2022-2029 (USD Million)
Table 375 Europe: Bioconjugation Scale-Up & Manufacturing Services Market, By Country, 2022-2029 (USD Million)
Table 376 Asia-Pacific: Bioconjugation Scale-Up & Manufacturing Services Market, by Country, 2022-2029 (USD Million)
Table 377 Latin America: Bioconjugation Scale-Up & Manufacturing Services Market, by Country, 2022-2029 (USD Million)
Table 378 Middle East: Bioconjugation Scale-Up & Manufacturing Services Market, by Region, 2022-2029 (USD Million)
Table 379 GCC Countries: Bioconjugation Scale-Up & Manufacturing Services Market, by Country, 2022-2029 (USD Million)
Table 380 Other Bioconjugation Services Market, by Region, 2022-2029 (USD Million)
Table 381 North America: Other Bioconjugation Services Market, by Country, 2022-2029 (USD Million)
Table 382 Europe: Other Bioconjugation Services Market, by Country, 2022-2029 (USD Million)
Table 383 Asia-Pacific: Other Bioconjugation Services Market, by Country, 2022-2029 (USD Million)
Table 384 Latin America: Other Bioconjugation Services Market, by Country, 2022-2029 (USD Million)
Table 385 Middle East: Other Bioconjugation Services Market, by Region, 2022-2029 (USD Million)
Table 386 GCC Countries: Other Bioconjugation Services Market, by Country, 2022-2029 (USD Million)
Table 387 Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 388 Antibody Conjugation Services Market, by Region, 2022-2029 (USD Million)
Table 389 North America: Antibody Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 390 Europe: Antibody Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 391 Asia-Pacific: Antibody Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 392 Latin America: Antibody Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 393 Middle East: Antibody Conjugation Services Market, by Region, 2022-2029 (USD Million)
Table 394 GCC Countries: Antibody Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 395 Peptide Conjugation Services Market, by Region, 2022-2029 (USD Million)
Table 396 North America: Peptide Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 397 Europe: Peptide Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 398 Asia-Pacific: Peptide Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 399 Latin America: Peptide Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 400 Middle East: Peptide Conjugation Services Market, by Region, 2022-2029 (USD Million)
Table 401 GCC Countries: Peptide Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 402 Protein Conjugation Services Market, by Region, 2022-2029 (USD Million)
Table 403 North America: Protein Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 404 Europe: Protein Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 405 Asia-Pacific: Protein Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 406 Latin America: Protein Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 407 Middle East: Protein Conjugation Services Market, by Region, 2022-2029 (USD Million)
Table 408 GCC Countries: Protein Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 409 Oligonucleotide Conjugation Services Market, by Region, 2022-2029 (USD Million)
Table 410 North America: Oligonucleotide Conjugation Services Market, By Country, 2022-2029 (USD Million)
Table 411 Europe: Oligonucleotide Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 412 Asia-Pacific: Oligonucleotide Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 413 Latin America: Oligonucleotide Conjugation Services Market, By Region, 2022-2029 (USD Million)
Table 414 Middle East: Oligonucleotide Conjugation Services Market, By Country, 2022-2029 (USD Million)
Table 415 GCC Countries: Oligonucleotide Conjugation Services Market, By Country, 2022-2029 (USD Million)
Table 416 Other Conjugation Services Market, by Region, 2022-2029 (USD Million)
Table 417 North America: Other Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 418 Europe: Other Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 419 Asia-Pacific: Other Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 420 Latin America: Other Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 421 Middle East: Other Conjugation Services Market, by Region, 2022-2029 (USD Million)
Table 422 GCC Countries: Other Conjugation Services Market, by Country, 2022-2029 (USD Million)
Table 423 Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 424 Bioconjugation Services Market for Chemical Conjugation, by Region, 2022-2029 (USD Million)
Table 425 North America: Bioconjugation Services Market for Chemical Conjugation, by Country, 2022-2029 (USD Million)
Table 426 Europe: Bioconjugation Services Market for Chemical Conjugation, By Country, 2022-2029 (USD Million)
Table 427 Asia-Pacific: Bioconjugation Services Market for Chemical Conjugation, by Country, 2022-2029 (USD Million)
Table 428 Latin America: Bioconjugation Services Market for Chemical Conjugation, by Country, 2022-2029 (USD Million)
Table 429 Middle East: Bioconjugation Services Market for Chemical Conjugation, by Region, 2022-2029 (USD Million)
Table 430 GCC Countries: Bioconjugation Services Market for Chemical Conjugation, by Country, 2022-2029 (USD Million)
Table 431 Bioconjugation Services Market for Click Chemistry, by Region, 2022-2029 (USD Million)
Table 432 North America: Bioconjugation Services Market for Click Chemistry, by Country, 2022-2029 (USD Million)
Table 433 Europe: Bioconjugation Services Market for Click Chemistry, By Country, 2022-2029 (USD Million)
Table 434 Asia-Pacific: Bioconjugation Services Market for Click Chemistry, By Country, 2022-2029 (USD Million)
Table 435 Latin America: Bioconjugation Services Market for Click Chemistry, By Country, 2022-2029 (USD Million)
Table 436 Middle East: Bioconjugation Services Market for Click Chemistry, By Region, 2022-2029 (USD Million)
Table 437 GCC Countries: Bioconjugation Services Market for Click Chemistry, By Country, 2022-2029 (USD Million)
Table 438 Bioconjugation Services Market for Enzyme-Mediated Conjugation, By Region, 2022-2029 (USD Million)
Table 439 North America: Bioconjugation Services Market for Enzyme-Mediated Conjugation, by Country, 2022-2029 (USD Million)
Table 440 Europe: Bioconjugation Services Market for Enzyme-Mediated Conjugation, by Country, 2022-2029 (USD Million)
Table 441 Asia-Pacific: Bioconjugation Services Market for Enzyme-Mediated Conjugation, by Country, 2022-2029 (USD Million)
Table 442 Latin America: Bioconjugation Services Market for Enzyme-Mediated Conjugation, by Country, 2022-2029 (USD Million)
Table 443 Middle East: Bioconjugation Services Market for Enzyme-Mediated Conjugation, by Region, 2022-2029 (USD Million)
Table 444 GCC Countries: Bioconjugation Services Market for Enzyme-Mediated Conjugation, by Country, 2022-2029 (USD Million)
Table 445 Bioconjugation Services Market for Photoreactive Crosslinking, By Region, 2022-2029 (USD Million)
Table 446 North America: Bioconjugation Services Market for Photoreactive Crosslinking, by Country, 2022-2029 (USD Million)
Table 447 Europe: Bioconjugation Services Market for Photoreactive Crosslinking, by Country, 2022-2029 (USD Million)
Table 448 Asia-Pacific: Bioconjugation Services Market for Photoreactive Crosslinking, by Country, 2022-2029 (USD Million)
Table 449 Latin America: Bioconjugation Services Market for Photoreactive Crosslinking, by Country, 2022-2029 (USD Million)
Table 450 Middle East: Bioconjugation Services Market for Photoreactive Crosslinking, by Region, 2022-2029 (USD Million)
Table 451 GCC Countries: Bioconjugation Services Market for Photoreactive Crosslinking, by Country, 2022-2029 (USD Million)
Table 452 Bioconjugation Services Market for Other Techniques, by Region, 2022-2029 (USD Million)
Table 453 North America: Bioconjugation Services Market for Other Techniques, by Country, 2022-2029 (USD Million)
Table 454 Europe: Bioconjugation Services Market for Other Techniques, By Country, 2022-2029 (USD Million)
Table 455 Asia-Pacific: Bioconjugation Services Market for Other Techniques, By Country, 2022-2029 (USD Million)
Table 456 Latin America: Bioconjugation Services Market for Other Techniques, by Country, 2022-2029 (USD Million)
Table 457 Middle East: Bioconjugation Services Market for Other Techniques, By Country, 2022-2029 (USD Million)
Table 458 GCC Countries: Bioconjugation Services Market for Other Techniques, by Country, 2022-2029 (USD Million)
Table 459 Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 460 Bioconjugation Services Market for Therapeutic Applications, By Region, 2022-2029 (USD Million)
Table 461 North America: Bioconjugation Services Market for Therapeutic Applications, by Country, 2022-2029 (USD Million)
Table 462 Europe: Bioconjugation Services Market for Therapeutic Applications, by Country, 2022-2029 (USD Million)
Table 463 Asia-Pacific: Bioconjugation Services Market for Therapeutic Applications, by Country, 2022-2029 (USD Million)
Table 464 Latin America: Bioconjugation Services Market for Therapeutic Applications, by Country, 2022-2029 (USD Million)
Table 465 Middle East: Bioconjugation Services Market for Therapeutic Applications, by Region, 2022-2029 (USD Million)
Table 466 GCC Countries: Bioconjugation Services Market for Therapeutic Applications, by Country, 2022-2029 (USD Million)
Table 467 Bioconjugation Services Market for Research & Development Applications, by Region, 2022-2029 (USD Million)
Table 468 North America: Bioconjugation Services Market for Research & Development Applications, by Country, 2022-2029 (USD Million)
Table 469 Europe: Bioconjugation Services Market for Research & Development Applications, by Country, 2022-2029 (USD Million)
Table 470 Asia-Pacific: Bioconjugation Services Market for Research & Development Applications, by Country, 2022-2029 (USD Million)
Table 471 Latin America: Bioconjugation Services Market for Research & Development Applications, by Country, 2022-2029 (USD Million)
Table 472 Middle East: Bioconjugation Services Market for Research & Development Applications, by Region, 2022-2029 (USD Million)
Table 473 GCC Countries: Bioconjugation Services Market for Research & Development Application, by Country, 2022-2029 (USD Million)
Table 474 Bioconjugation Services Market for Diagnostic Applications, By Region, 2022-2029 (USD Million)
Table 475 North America: Bioconjugation Services Market for Diagnostic Applications, by Country, 2022-2029 (USD Million)
Table 476 Europe: Bioconjugation Services Market for Diagnostic Applications, by Country, 2022-2029 (USD Million)
Table 477 Asia-Pacific: Bioconjugation Services Market for Diagnostic Applications, by Country, 2022-2029 (USD Million)
Table 478 Latin America: Bioconjugation Services Market for Diagnostic Applications, by Country, 2022-2029 (USD Million)
Table 479 Middle East: Bioconjugation Services Market for Diagnostic Applications, by Region, 2022-2029 (USD Million)
Table 480 GCC Countries: Bioconjugation Services Market for Diagnostic Applications, by Country, 2022-2029 (USD Million)
Table 481 Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 482 Bioconjugation Services Market for Pharmaceutical & Biotechnology Companies, by Region, 2022-2029 (USD Million)
Table 483 North America: Bioconjugation Services Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 484 Europe: Bioconjugation Services Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 485 Asia-Pacific: Bioconjugation Services Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 486 Latin America: Bioconjugation Services Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 487 Middle East: Bioconjugation Services Market for Pharmaceutical & Biotechnology Companies, by Region, 2022-2029 (USD Million)
Table 488 GCC Countries: Bioconjugation Services Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 489 Bioconjugation Services Market for Academic & Research Institutes, by Region, 2022-2029 (USD Million)
Table 490 North America: Bioconjugation Services Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 491 Europe: Bioconjugation Services Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 492 Asia-Pacific: Bioconjugation Services Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 493 Latin America: Bioconjugation Services Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 494 Middle East: Bioconjugation Services Market for Academic & Research Institutes, by Region, 2022-2029 (USD Million)
Table 495 GCC Countries: Bioconjugation Services Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 496 Bioconjugation Services Market for Hospitals and Clinical/Diagnostic Laboratories, by Region, 2022-2029 (USD Million)
Table 497 North America: Bioconjugation Services Market for Hospitals and Clinical/Diagnostic Laboratories, by Country, 2022-2029 (USD Million)
Table 498 Europe: Bioconjugation Services Market for Hospitals and Clinical/Diagnostic Laboratories, by Country, 2022-2029 (USD Million)
Table 499 Asia-Pacific: Bioconjugation Services Market for Hospitals and Clinical/Diagnostic Laboratories, by Country, 2022-2029 (USD Million)
Table 500 Latin America: Bioconjugation Services Market for Hospitals and Clinical/Diagnostic Laboratories, by Country, 2022-2029 (USD Million)
Table 501 Middle East: Bioconjugation Services Market for Hospitals and Clinical/Diagnostic Laboratories, by Region, 2022-2029 (USD Million)
Table 502 GCC Countries: Bioconjugation Services Market for Hospitals and Clinical/Diagnostic Laboratories, by Country, 2022-2029 (USD Million)
Table 503 Bioconjugation Market, by Region, 2022-2029 (USD Million)
Table 504 Bioconjugation Products Market, by Region, 2022-2029 (USD Million)
Table 505 Bioconjugation Services Market, by Region, 2022-2029 (USD Million)
Table 506 North America: Bioconjugation Market, by Country, 2022-2029 (USD Million)
Table 507 North America: Bioconjugation Products Market, by Country, 2022-2029 (USD Million)
Table 508 North America: Bioconjugation Services Market, by Country, 2022-2029 (USD Million)
Table 509 North America: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 510 North America: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 511 North America: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 512 North America: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 513 North America: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 514 North America: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 515 North America: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 516 North America: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 517 North America: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 518 North America: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 519 North America: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 520 North America: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 521 North America: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 522 North America: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 523 North America: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 524 North America: Key Macroindicators
Table 525 US: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 526 US: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 527 US: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 528 US: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 529 US: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 530 US: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 531 US: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 532 US: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 533 US: Bioconjugation Products Market for Therapeutic Applications, By Type, 2022-2029 (USD Million)
Table 534 US: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 535 US: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 536 US: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 537 US: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 538 US: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 539 US: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 540 Canada: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 541 Canada: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 542 Canada: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 543 Canada: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 544 Canada: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 545 Canada: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 546 Canada: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 547 Canada: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 548 Canada: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 549 Canada: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 550 Canada: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 551 Canada: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 552 Canada: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 553 Canada: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 554 Canada: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 555 Europe: Bioconjugation Market, by Country, 2022-2029 (USD Million)
Table 556 Europe: Bioconjugation Products Market, by Country, 2022-2029 (USD Million)
Table 557 Europe: Bioconjugation Services Market, by Country, 2022-2029 (USD Million)
Table 558 Europe: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 559 Europe: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 560 Europe: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 561 Europe: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 562 Europe: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 563 Europe: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 564 Europe: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 565 Europe: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 566 Europe: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 567 Europe: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 568 Europe: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 569 Europe: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 570 Europe: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 571 Europe: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 572 Europe: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 573 Europe: Key Macroindicators
Table 574 Germany: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 575 Germany: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 576 Germany: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 577 Germany: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 578 Germany: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 579 Germany: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 580 Germany: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 581 Germany: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 582 Germany: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 583 Germany: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 584 Germany: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 585 Germany: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 586 Germany: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 587 Germany: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 588 Germany: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 589 UK: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 590 UK: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 591 UK: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 592 UK: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 593 UK: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 594 UK: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 595 UK: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 596 UK: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 597 UK: Bioconjugation Products Market for Therapeutic Applications, By Type, 2022-2029 (USD Million)
Table 598 UK: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 599 UK: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 600 UK: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 601 UK: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 602 UK: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 603 UK: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 604 France: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 605 France: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 606 France: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 607 France: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 608 France: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 609 France: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 610 France: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 611 France: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 612 France: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 613 France: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 614 France: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 615 France: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 616 France: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 617 France: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 618 France: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 619 Italy: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 620 Italy: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 621 Italy: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 622 Italy: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 623 Italy: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 624 Italy: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 625 Italy: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 626 Italy: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 627 Italy: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 628 Italy: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 629 Italy: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 630 Italy: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 631 Italy: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 632 Italy: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 633 Italy: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 634 Spain: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 635 Spain: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 636 Spain: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 637 Spain: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 638 Spain: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 639 Spain: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 640 Spain: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 641 Spain: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 642 Spain: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 643 Spain: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 644 Spain: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 645 Spain: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 646 Spain: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 647 Spain: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 648 Spain: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 649 Rest of Europe: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 650 Rest of Europe: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 651 Rest of Europe: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 652 Rest of Europe: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 653 Rest of Europe: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 654 Rest of Europe: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 655 Rest of Europe: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 656 Rest of Europe: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 657 Rest of Europe: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 658 Rest of Europe: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 659 Rest of Europe: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 660 Rest of Europe: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 661 Rest of Europe: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 662 Rest of Europe: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 663 Rest of Europe: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 664 Asia-Pacific: Bioconjugation Market, by Country, 2022-2029 (USD Million)
Table 665 Asia-Pacific: Bioconjugation Products Market, by Country, 2022-2029 (USD Million)
Table 666 Asia-Pacific: Bioconjugation Services Market, by Country, 2022-2029 (USD Million)
Table 667 Asia-Pacific: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 668 Asia-Pacific: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 669 Asia-Pacific: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 670 Asia-Pacific: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 671 Asia-Pacific: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 672 Asia-Pacific: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 673 Asia-Pacific: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 674 Asia-Pacific: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 675 Asia-Pacific: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 676 Asia-Pacific: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 677 Asia-Pacific: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 678 Asia-Pacific: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 679 Asia-Pacific: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 680 Asia-Pacific: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 681 Asia-Pacific: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 682 Asia-Pacific: Key Macroindicators
Table 683 China: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 684 China: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 685 China: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 686 China: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 687 China: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 688 China: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 689 China: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 690 China: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 691 China: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 692 China: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 693 China: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 694 China: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 695 China: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 696 China: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 697 China: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 698 Japan: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 699 Japan: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 700 Japan: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 701 Japan: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 702 Japan: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 703 Japan: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 704 Japan: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 705 Japan: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 706 Japan: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 707 Japan: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 708 Japan: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 709 Japan: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 710 Japan: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 711 Japan: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 712 Japan: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 713 India: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 714 India: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 715 India: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 716 India: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 717 India: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 718 India: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 719 India: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 720 India: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 721 India: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 722 India: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 723 India: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 724 India: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 725 India: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 726 India: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 727 India: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 728 South Korea: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 729 South Korea: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 730 South Korea: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 731 South Korea: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 732 South Korea: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 733 South Korea: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 734 South Korea: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 735 South Korea: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 736 South Korea: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 737 South Korea: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 738 South Korea: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 739 South Korea: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 740 South Korea: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 741 South Korea: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 742 South Korea: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 743 Australia: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 744 Australia: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 745 Australia: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 746 Australia: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 747 Australia: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 748 Australia: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 749 Australia: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 750 Australia: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 751 Australia: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 752 Australia: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 753 Australia: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 754 Australia: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 755 Australia: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 756 Australia: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 757 Australia: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 758 Rest of Asia-Pacific: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 759 Rest of Asia-Pacific: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 760 Rest of Asia-Pacific: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 761 Rest of Asia-Pacific: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 762 Rest of Asia-Pacific: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 763 Rest of Asia-Pacific: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 764 Rest of Asia-Pacific: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 765 Rest of Asia-Pacific: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 766 Rest of Asia-Pacific: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 767 Rest of Asia-Pacific: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 768 Rest of Asia-Pacific: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 769 Rest of Asia-Pacific: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 770 Rest of Asia-Pacific: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 771 Rest of Asia-Pacific: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 772 Rest of Asia-Pacific: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 773 Latin America: Bioconjugation Market, by Country, 2022-2029 (USD Million)
Table 774 Latin America: Bioconjugation Products Market, by Country, 2022-2029 (USD Million)
Table 775 Latin America: Bioconjugation Services Market, by Country, 2022-2029 (USD Million)
Table 776 Latin America: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 777 Latin America: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 778 Latin America: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 779 Latin America: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 780 Latin America: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 781 Latin America: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 782 Latin America: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 783 Latin America: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 784 Latin America: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 785 Latin America: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 786 Latin America: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 787 Latin America: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 788 Latin America: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 789 Latin America: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 790 Latin America: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 791 Latin America: Key Macroindicators
Table 792 Brazil: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 793 Brazil: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 794 Brazil: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 795 Brazil: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 796 Brazil: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 797 Brazil: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 798 Brazil: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 799 Brazil: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 800 Brazil: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 801 Brazil: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 802 Brazil: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 803 Brazil: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 804 Brazil: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 805 Brazil: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 806 Brazil: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 807 Mexico: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 808 Mexico: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 809 Mexico: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 810 Mexico: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 811 Mexico: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 812 Mexico: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 813 Mexico: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 814 Mexico: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 815 Mexico: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 816 Mexico: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 817 Mexico: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 818 Mexico: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 819 Mexico: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 820 Mexico: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 821 Mexico: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 822 Rest of Latin America: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 823 Rest of Latin America: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 824 Rest of Latin America: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 825 Rest of Latin America: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 826 Rest of Latin America: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 827 Rest of Latin America: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 828 Rest of Latin America: Bioconjugation Products Market, By Biomolecule Type, 2022-2029 (USD Million)
Table 829 Rest of Latin America: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 830 Rest of Latin America: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 831 Rest of Latin America: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 832 Rest of Latin America: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 833 Rest of Latin America: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 834 Rest of Latin America: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 835 Rest of Latin America: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 836 Rest of Latin America: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 837 Middle East: Bioconjugation Market, by Region, 2022-2029 (USD Million)
Table 838 Middle East: Bioconjugation Products Market, by Region, 2022-2029 (USD Million)
Table 839 Middle East: Bioconjugation Services Market, by Region, 2022-2029 (USD Million)
Table 840 Middle East: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 841 Middle East: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 842 Middle East: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 843 Middle East: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 844 Middle East: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 845 Middle East: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 846 Middle East: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 847 Middle East: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 848 Middle East: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 849 Middle East: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 850 Middle East: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 851 Middle East: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 852 Middle East: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 853 Middle East: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 854 Middle East: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 855 Middle East: Key Macroindicators
Table 856 GCC Countries: Bioconjugation Market, by Country, 2022-2029 (USD Million)
Table 857 GCC Countries: Bioconjugation Products Market, by Country, 2022-2029 (USD Million)
Table 858 GCC Countries: Bioconjugation Services Market, by Country, 2022-2029 (USD Million)
Table 859 GCC Countries: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 860 GCC Countries: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 861 GCC Countries: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 862 GCC Countries: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 863 GCC Countries: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 864 GCC Countries: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 865 GCC Countries: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 866 GCC Countries: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 867 GCC Countries: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 868 GCC Countries: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 869 GCC Countries: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 870 GCC Countries: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 871 GCC Countries: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 872 GCC Countries: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 873 GCC Countries: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 874 Kingdom of Saudi Arabia: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 875 Kingdom of Saudi Arabia: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 876 Kingdom of Saudi Arabia: Bioconjugation Reagents & Kits Market, By Type, 2022-2029 (USD Million)
Table 877 Kingdom of Saudi Arabia: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 878 Kingdom of Saudi Arabia: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 879 Kingdom of Saudi Arabia: Bioconjugation Products Market, By Technique, 2022-2029 (USD Million)
Table 880 Kingdom of Saudi Arabia: Bioconjugation Products Market, By Biomolecule Type, 2022-2029 (USD Million)
Table 881 Kingdom of Saudi Arabia: Bioconjugation Products Market, By Application, 2022-2029 (USD Million)
Table 882 Kingdom of Saudi Arabia: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 883 Kingdom of Saudi Arabia: Bioconjugation Products Market, By End-user, 2022-2029 (USD Million)
Table 884 Kingdom of Saudi Arabia: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 885 Kingdom of Saudi Arabia: Bioconjugation Services Market, By Technique, 2022-2029 (USD Million)
Table 886 Kingdom of Saudi Arabia: Bioconjugation Services Market, By Conjugation Type, 2022-2029 (USD Million)
Table 887 Kingdom of Saudi Arabia: Bioconjugation Services Market, By Application, 2022-2029 (USD Million)
Table 888 Kingdom of Saudi Arabia: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 889 United Arab Emirates: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 890 United Arab Emirates: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 891 United Arab Emirates: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 892 United Arab Emirates: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 893 United Arab Emirates: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 894 United Arab Emirates: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 895 United Arab Emirates: Bioconjugation Products Market, By Biomolecule Type, 2022-2029 (USD Million)
Table 896 United Arab Emirates: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 897 United Arab Emirates: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 898 United Arab Emirates: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 899 United Arab Emirates: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 900 United Arab Emirates: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 901 United Arab Emirates: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 902 United Arab Emirates: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 903 United Arab Emirates: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 904 Other GCC Countries: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 905 Other GCC Countries: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 906 Other GCC Countries: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 907 Other GCC Countries: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 908 Other GCC Countries: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 909 Other GCC Countries: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 910 Other GCC Countries: Bioconjugation Products Market, By Biomolecule Type, 2022-2029 (USD Million)
Table 911 Other GCC Countries: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 912 Other GCC Countries: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 913 Other GCC Countries: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 914 Other GCC Countries: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 915 Other GCC Countries: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 916 Other GCC Countries: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 917 Other GCC Countries: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 918 Other GCC Countries: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 919 Rest of Middle East: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 920 Rest of Middle East: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 921 Rest of Middle East: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 922 Rest of Middle East: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 923 Rest of Middle East: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 924 Rest of Middle East: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 925 Rest of Middle East: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 926 Rest of Middle East: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 927 Rest of Middle East: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 928 Rest of Middle East: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 929 Rest of Middle East: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 930 Rest of Middle East: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 931 Rest of Middle East: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 932 Rest of Middle East: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 933 Rest of Middle East: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 934 Africa: Bioconjugation Products Market, by Type, 2022-2029 (USD Million)
Table 935 Africa: Bioconjugation Consumables Market, by Type, 2022-2029 (USD Million)
Table 936 Africa: Bioconjugation Reagents & Kits Market, by Type, 2022-2029 (USD Million)
Table 937 Africa: Bioconjugation Labels Market, by Type, 2022-2029 (USD Million)
Table 938 Africa: Bioconjugation Instruments Market, by Type, 2022-2029 (USD Million)
Table 939 Africa: Bioconjugation Products Market, by Technique, 2022-2029 (USD Million)
Table 940 Africa: Bioconjugation Products Market, by Biomolecule Type, 2022-2029 (USD Million)
Table 941 Africa: Bioconjugation Products Market, by Application, 2022-2029 (USD Million)
Table 942 Africa: Bioconjugation Products Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 943 Africa: Bioconjugation Products Market, by End-user, 2022-2029 (USD Million)
Table 944 Africa: Bioconjugation Services Market, by Type, 2022-2029 (USD Million)
Table 945 Africa: Bioconjugation Services Market, by Technique, 2022-2029 (USD Million)
Table 946 Africa: Bioconjugation Services Market, by Conjugation Type, 2022-2029 (USD Million)
Table 947 Africa: Bioconjugation Services Market, by Application, 2022-2029 (USD Million)
Table 948 Africa: Bioconjugation Services Market, by End-user, 2022-2029 (USD Million)
Table 949 Africa: Macroindicators
Table 950 Overview of Strategies Deployed by Key Manufacturing Companies
Table 951 Bioconjugation Market: Degree of Competition
Table 952 Bioconjugation Market: Product/Service Footprint
Table 953 Bioconjugation Market: Application Footprint
Table 954 Bioconjugation Market: End-user Footprint
Table 955 Bioconjugation Market: Region Footprint
Table 956 Bioconjugation Market: Detailed List of Key Startups/SMEs
Table 957 Bioconjugation Market: Competitive Benchmarking of Startups/SMEs
Table 958 Bioconjugation Market: Product/Service Launches, January 2021-August 2024
Table 959 Bioconjugation Market: Deals, January 2021-August 2024
Table 960 Bioconjugation Market: Expansions, January 2021-August 2024
Table 961 Danaher Corporation: Company Overview
Table 962 Danaher Corporation: Products/Services Offered
Table 963 Danaher Corporation: Product/Service Launches, January 2021-August 2024
Table 964 Danaher Corporation: Deals, January 2021-August 2024
Table 965 Danaher Corporation: Expansions, January 2021-June 2024
Table 966 Lonza: Company Overview
Table 967 Lonza: Products/Services Offered
Table 968 Lonza: Deals, January 2021-June 2024
Table 969 Lonza: Expansions, January 2021-June 2024
Table 970 Thermo Fisher Scientific Inc.: Company Overview
Table 971 Thermo Fisher Scientific Inc.: Products/Services Offered
Table 972 Thermo Fisher Scientific Inc.: Product/Service Launches, January 2021-June 2024
Table 973 Thermo Fisher Scientific Inc.: Deals, January 2021-June 2024
Table 974 Thermo Fisher Scientific Inc.: Expansions, January 2021-June 2024
Table 975 Merck KGaA: Company Overview
Table 976 Merck KGaA: Products/Services Offered
Table 977 Merck KGaA: Product/Service Launches, January 2021-June 2024
Table 978 Merck KGaA: Deals, January 2021-June 2024
Table 979 Merck KGaA: Expansions, January 2021-June 2024
Table 980 Abbvie Inc.: Company Overview
Table 981 Abbvie Inc.: Products/Services Offered
Table 982 Abbvie Inc.: Deals, January 2021-June 2024
Table 983 Abbvie Inc.: Expansions, January 2021-June 2024
Table 984 Wuxi Biologics (Cayman) Inc.: Company Overview
Table 985 Wuxi Biologics (Cayman) Inc.: Products/Services Offered
Table 986 Wuxi Biologics (Cayman) Inc.: Deals, January 2021-June 2024
Table 987 Wuxi Biologics (Cayman) Inc.: Expansions, January 2021-June 2024
Table 988 Sartorius AG: Company Overview
Table 989 Sartorius AG: Products/Services Offered
Table 990 Sartorius AG: Deals, January 2021-June 2024
Table 991 Sartorius AG: Expansions, January 2021-June 2024
Table 992 Bio-Rad Laboratories, Inc.: Company Overview
Table 993 Bio-Rad Laboratories, Inc.: Products/Services Offered
Table 994 Catalent, Inc.: Company Overview
Table 995 Catalent, Inc.: Products/Services Offered
Table 996 Catalent, Inc.: Product/Service Launches, January 2021-June 2024
Table 997 Catalent, Inc.: Deals, January 2021-June 2024
Table 998 Catalent, Inc.: Expansions, January 2021-August 2024
Table 999 Beckton, Dickinson and Company: Company Overview
Table 1000 Bd: Products/Services Offered
Table 1001 Bd: Product/Service Launches, January 2021-August 2024
Table 1002 Bd: Deals, January 2021-August 2024
Table 1003 Agilent Technologies, Inc.: Company Overview
Table 1004 Agilent Technologies, Inc.: Products/Services Offered
Table 1005 Agilent Technologies, Inc.: Product/Service Launches, January 2021-August 2024
Table 1006 Agilent Technologies, Inc.: Deals, January 2021-August 2024
Table 1007 Agilent Technologies, Inc.: Expansions, January 2021-August 2024
Table 1008 Promega Corporation: Company Overview
Table 1009 Promega Corporation: Products/Services Offered
Table 1010 F. Hoffmann-La Roche Ltd.: Company Overview
Table 1011 F. Hoffmann-La Roche Ltd.: Products/Services Offered
Table 1012 Charles River Laboratories: Company Overview
Table 1013 Charles River Laboratories: Products/Services Offered
Table 1014 Charles River Laboratories: Deals, January 2021-August 2024
Table 1015 Genscript Biotech Corporation: Company Overview
Table 1016 Genscript Biotech Corporation: Products/Services Offered
Table 1017 Genscript Biotech Corporation: Deals, January 2021-August 2024
Table 1018 Piramal Pharma Limited: Company Overview
Table 1019 Piramal Pharma Limited: Products/Services Offered
Table 1020 Piramal Pharma Limited: Product/Service Launches, January 2021-August 2024
Table 1021 Piramal Pharma Limited: Expansions, January 2021-August 2024
Table 1022 Abzena Ltd.: Company Overview
Table 1023 New England Biolabs: Company Overview
Table 1024 Biosynth: Company Overview
Table 1025 Cell Signaling Technology, Inc.: Company Overview
Table 1026 Creative Biolabs: Company Overview
Table 1027 Formosa Laboratories Inc.: Company Overview
Table 1028 Nj Bio, Inc.: Company Overview
Table 1029 Rockland Immunochemicals, Inc.: Company Overview
Table 1030 Shanghai Chempartner: Company Overview
Table 1031 Sterling Pharma Solutions Limited: Company Overview
Table 1032 Syngene International Limited: Company Overview
Table 1033 Tokyo Chemical Industry Co. Ltd.: Company Overview
Table 1034 Vector Laboratories, Inc.: Company Overview
List of Figures
Figure 1 Research Design
Figure 2 Breakdown of Primaries: Bioconjugation Market
Figure 3 Bioconjugation Market Size Estimation (Supply-Side Analysis), 2023
Figure 4 Global Market Size Estimation Approach 1 (Company Revenue Analysis-based Estimation), 2023
Figure 5 Illustrative Example of Thermo Fisher Scientific Inc.: Revenue Share Analysis (2023)
Figure 6 Market Size Validation from Primary Sources
Figure 7 Market Size Estimation Methodology: Top-Down Approach
Figure 8 Bioconjugation Market: CAGR Projections
Figure 9 Data Triangulation Methodology
Figure 10 Bioconjugation Products Market, by Type, 2024 vs. 2029 (USD Million)
Figure 11 Bioconjugation Products Market, by Technique, 2024 vs. 2029 (USD Million)
Figure 12 Bioconjugation Products Market, by Biomolecule Type, 2024 vs. 2029 (USD Million)
Figure 13 Bioconjugation Products Market, by Application, 2024 vs. 2029 (USD Million)
Figure 14 Bioconjugation Products Market, by End-user, 2024 vs. 2029 (USD Million)
Figure 15 Bioconjugation Services Market, by Type, 2024 vs. 2029 (USD Million)
Figure 16 Bioconjugation Services Market, by Technique, 2024 vs. 2029 (USD Million)
Figure 17 Bioconjugation Services Market, by Conjugation Type, 2024 vs. 2029 (USD Million)
Figure 18 Bioconjugation Services Market, by Application, 2024 vs. 2029 (USD Million)
Figure 19 Bioconjugation Services Market, by End-user, 2024 vs. 2029 (USD Million)
Figure 20 Geographic Snapshot of Bioconjugation Market
Figure 21 Growing Demand for Targeted Therapies to Drive Market
Figure 22 Therapeutics Segment Accounted for Largest Market Share in US In 2023
Figure 23 Consumables Segment Accounted for Largest Market Share in 2023
Figure 24 Pharmaceutical & Biotechnology Companies Segment Accounted for Largest Market Share in 2023
Figure 25 Custom Synthesis & Conjugation Services Segment Accounted for Larger Market Share in 2023
Figure 26 Emerging Economies to Register Higher Growth Rates During Forecast Period
Figure 27 Bioconjugation Market: Drivers, Restraints, Opportunities, and Challenges
Figure 28 Commercial Antibody-Drug Conjugate (Adc) Investigational New Drug (Ind) Submissions, 1993-2024
Figure 29 Revenue Shifts in Bioconjugation Market
Figure 30 Bioconjugation Market: Supply Chain Analysis
Figure 31 Bioconjugation Market: Value Chain Analysis
Figure 32 Bioconjugation Market: Ecosystem Market Map
Figure 33 Number of Patents Applications/Granted, 2014-2024
Figure 34 Bioconjugation Market: Porter's Five Forces Analysis
Figure 35 Influence of Stakeholders on Buying Process of Bioconjugation Products
Figure 36 Key Buying Criteria for Bioconjugation Products
Figure 37 Bioconjugation Market: Impact of AI
Figure 38 Adcs Entering Clinical Trials, 2012-2022
Figure 39 Number of Documents (Journal Articles and Patents) in Cas Content Collection for Adc R&D
Figure 40 North America: Bioconjugation Market Snapshot
Figure 41 US: Funding by Nih, 2014-2024
Figure 42 Asia-Pacific: Bioconjugation Market Snapshot
Figure 43 Revenue Analysis of Key Players in Bioconjugation Market, 2019-2023
Figure 44 Market Share Analysis of Key Players in Bioconjugation Market, 2023
Figure 45 Bioconjugation Market: Company Evaluation Matrix (Key Players), 2023
Figure 46 Bioconjugation Market: Company Footprint
Figure 47 Bioconjugation Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 48 EV/EBITDA of Key Vendors
Figure 49 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 50 Bioconjugation Market: Brand/Product/Service Comparison
Figure 51 Danaher Corporation: Company Snapshot (2023)
Figure 52 Lonza: Company Snapshot (2023)
Figure 53 Thermo Fisher Scientific Inc.: Company Snapshot (2023)
Figure 54 Merck KGaA: Company Snapshot (2023)
Figure 55 Abbvie Inc.: Company Snapshot (2023)
Figure 56 Wuxi Biologics (Cayman) Inc.: Company Snapshot (2023)
Figure 57 Sartorius AG: Company Snapshot (2023)
Figure 58 Bio-Rad Laboratories, Inc.: Company Snapshot (2023)
Figure 59 Catalent, Inc.: Company Snapshot (2023)
Figure 60 Beckton, Dickinson and Company: Company Snapshot (2023)
Figure 61 Agilent Technologies, Inc.: Company Snapshot (2023)
Figure 62 F. Hoffmann-La Roche Ltd.: Company Snapshot (2023)
Figure 63 Charles River Laboratories: Company Snapshot (2023)
Figure 64 Genscript Biotech Corporation: Company Snapshot (2023)
Figure 65 Piramal Pharma Limited: Company Snapshot (2023)

Companies Mentioned

  • Danaher Corporation
  • Lonza
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Abbvie Inc.
  • Wuxi Biologics (Cayman) Inc.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • Catalent, Inc.
  • Beckton, Dickinson and Company
  • Agilent Technologies, Inc.
  • Promega Corporation
  • F. Hoffmann-La Roche Ltd.
  • Charles River Laboratories
  • Genscript Biotech Corporation
  • Piramal Pharma Limited
  • Abzena Ltd.
  • New England Biolabs
  • Biosynth
  • Cell Signaling Technology, Inc.
  • Creative Biolabs
  • Formosa Laboratories Inc.
  • Nj Bio, Inc.
  • Rockland Immunochemicals, Inc.
  • Shanghai Chempartner
  • Sterling Pharma Solutions Limited
  • Syngene International Limited
  • Tokyo Chemical Industry Co. Ltd.
  • Vector Laboratories, Inc.

Table Information